Protara Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TARA and other ETFs, options, and stocks.About TARA
Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders.
CEOJesse Shefferman
CEOJesse Shefferman
Employees33
Employees33
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2006
Founded2006
Employees33
Employees33
TARA Key Statistics
Market cap265.29M
Market cap265.29M
Price-Earnings ratio-4.71
Price-Earnings ratio-4.71
Dividend yield—
Dividend yield—
Average volume968.43K
Average volume968.43K
High today$7.05
High today$7.05
Low today$5.96
Low today$5.96
Open price$6.69
Open price$6.69
Volume729.81K
Volume729.81K
52 Week high$10.48
52 Week high$10.48
52 Week low$2.77
52 Week low$2.77
Stock Snapshot
Protara Therapeutics(TARA) stock is priced at $6.03, giving the company a market capitalization of 265.29M. It carries a P/E multiple of -4.71.
During the trading session on 2025-12-04, Protara Therapeutics(TARA) shares reached a daily high of $7.05 and a low of $5.96. At a current price of $6.03, the stock is +1.2% higher than the low and still -14.5% under the high.
Trading activity shows a volume of 729.81K, compared to an average daily volume of 968.43K.
Over the past 52 weeks, Protara Therapeutics(TARA) stock has traded between a high of $10.48 and a low of $2.77.
Over the past 52 weeks, Protara Therapeutics(TARA) stock has traded between a high of $10.48 and a low of $2.77.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own TARA. This list is generated using Robinhood data, and it’s not a recommendation.